Acquired Immunodeficiency Syndrome (AIDS) Market: Industry Analysis, Epidemiology, Treatment, Therapies and Key Companies | DelveInsight

 Acquired Immunodeficiency Syndrome (AIDS) is the most severe stage of HIV infection, when a person’s CD4 cell count drops below 200 cells/mm and the person’s immune system is no longer able to control viral infection. AIDS is caused by Human Immunodeficiency Virus (HIV). It is transmitted sexually, via blood transfusions, sharing intravenous needles, and from the mother to a child during the birth process and breastfeeding.

DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2030" report delivers an in-depth understanding of the Acquired Immunodeficiency Syndrome (AIDS), historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome (AIDS) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Some facts of the AIDS Market Report are:

·         According to the latest estimates from the CDC, approximately 34,800 new HIV infections were diagnosed in the United States in 2019.

·         CDC estimates of annual HIV infections in the United States show a declining trend in recent years.

·         At year-end 2019, an estimated 1.2 million people in the United States aged 13 and older had HIV.

·         According to another CDC report, of the estimated 1.2 million people with HIV (diagnosed and undiagnosed) in 2019, about 65.9% received some HIV care, 50.1% were retained in care, and 56.8% were virally suppressed or undetectable.

·         Transgender people accounted for approximately 2% of new HIV diagnoses in 2019. There is an increasing need for updated HIV drugs that can treat prevalent patient population as it faces challenges like Multi-Drug Resistance, declining-response to ART (Anti-retroviral therapy). This poses a great opportunity to exploit, considering significant disease burden in 7MM. AIDS Market looks robust with a long pipeline of both drugs & vaccines candidates.

View Report: https://www.delveinsight.com/report-store/acquired-immunodeficiency-syndrome-aids-market

Request for Sample Report: https://www.delveinsight.com/sample-request/acquired-immunodeficiency-syndrome-aids-market

Treatment of AIDS is focused on the opportunistic illness or condition and decreasing the HIV viral load and monitoring for an increase in CD4 cells through antiretroviral therapy (ART.) VOCABRIA (Cabotegravir) is a human immunodeficiency virus type-1 (HIV-1) integrase strand transfer inhibitor. The multi-class combination drugs segment holds the largest market share as it involves the most advanced technique used for the treatment of HIV infection.

Furthermore, this is attributed to the increase in adoption, owing to their better results in the control of HIV & related co-infections and their ease in consumption & adherence.

The prevalence of HIV/AIDS has increased over recent years with advancements in treatment allowing patients to live longer with HIV. However, there has been a reduction in incidence numbers since the 1990s. While efforts in developed countries have led to improvements in mortality, quality of life, and transmission rates. Nonetheless, US leads the market with major share, by geography among the 7MM.

View Report: https://www.delveinsight.com/report-store/acquired-immunodeficiency-syndrome-aids-market

Request for Sample Report: https://www.delveinsight.com/sample-request/acquired-immunodeficiency-syndrome-aids-market

Some of Acquired Immunodeficiency Syndrome Companies are:

·         ViiV Healthcare

·         Johnson and Johnson

·         Aelix Therapeutics

·         Gilead

·         And Many Others

Acquired Immunodeficiency Syndrome Therapies covered:

·         Cabotegravir (Vocabria)

·         VAC89220

·         HTI Immunogen Sequence

·         bNAbs (GS-5423 + GS-2872)

·         And Many Others

View Report: https://www.delveinsight.com/report-store/acquired-immunodeficiency-syndrome-aids-market

Request for Sample Report: https://www.delveinsight.com/sample-request/acquired-immunodeficiency-syndrome-aids-market

Table of Contents:

1. Key Insights

2. Executive Summary of Acquired Immunodeficiency Syndrome (AIDS)

3. Competitive Intelligence Analysis for Acquired Immunodeficiency Syndrome (AIDS)

4. Acquired Immunodeficiency Syndrome (AIDS): Market Overview at a Glance

5. Acquired Immunodeficiency Syndrome (AIDS): Disease Background and Overview

6. Patient Journey

7. Acquired Immunodeficiency Syndrome (AIDS) Epidemiology and Patient Population

8. Treatment Algorithm, Current Treatment, and Medical Practices

9. Unmet Needs

10. Key Endpoints of Acquired Immunodeficiency Syndrome (AIDS) Treatment

11. Marketed Products

List to be continued in report

12. Emerging Therapies

List to be continued in report

13. Acquired Immunodeficiency Syndrome (AIDS): Seven Major Market Analysis

14. Attribute analysis

15. 7MM: Market Outlook

16. Access and Reimbursement Overview of Acquired Immunodeficiency Syndrome (AIDS)

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

Get in touch with our Business executive for Regulatory Analysis, Licensing Services, and Consulting Solutions 

Other Links:

·         Acquired Immunodeficiency Syndrome (AIDS) Market

·         Bladder pain syndrome Market

·         Cardiac Arrythmia Market

·         Cardiorenal Syndrome Market

·         Carpal Tunnel Syndrome Market

·         Central Retinal Venous Occulsion Market

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.  Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

Contact us

 Ankit Nigam

 info@delveinsight.com

 +91-9650213330

 https://www.delveinsight.com/

 Connect With Us at:

 LinkedIn | Facebook | Twitter

 

 

Comments

Post a Comment

Popular posts from this blog

How Competitive intelligence is transforming the scenario for Biotech firms?

What is Competitive intelligence service? Competitive intelligence ideally means gathering information on rival business in the market, analyse the information and use the information to strategize to yield positive results. Going by the definition, competitive intelligence assembles actionable information from diverse published and unpublished sources, collected efficiently and ethically. So, analysts performing Competitive intelligence for their clienteles present a detailed picture of the marketplace, forthcoming challenges and the ways to face them, even before the can harm the client’s business. What could it mean? Competitive intelligence can often give a wrong idea, as it may misunderstood as a service which can help gain an advantage over the rivals. However, this is not the case. Competitive intelligence is an ethical and legal practise undertaken involving the study of analytical data, analysing the market and optimizing the relevant and realistic strategies t...
Read more

Cervical Intraepithelial Neoplasia Market and Epidemiology 2032 by DelveInsight

DelveInsight's " Cervical Intraepithelial Neoplasia Market Insights, Epidemiology, and Market Forecast-2032 " report delivers an in-depth understanding of Cervical Intraepithelial Neoplasia, historical and forecasted epidemiology as well as the Cervical Intraepithelial Neoplasia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Cervical Intraepithelial Neoplasia market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Cervical Intraepithelial Neoplasia market size from 2019 to 2032, segmented by seven major markets. The Report also covers current Cervical Intraepithelial Neoplasia treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best opportunities and assesses the underlying potential of the Cervical Intraepithelial Neoplasia market. Request for a Free Sample Report: Cervic...
Read more

The Need And The Importance Of The Healthcare Reports for the Pharma Companies

Image
It is very important for the hospitals and the other medical institutions to preserve and keep the healthcare reports of all the patients very safe and secure. All the medical records are being kept by almost all of these institutes. As a matter of fact, the healthcare reports are very important for comprehending the medical history of the patient. If he or she suffers from the same ailment once more the previous reports will be absolutely indispensible while treating him or her. Nowadays, with the advancement of technology the manual records are slowly and gradually getting digitalized. It is easier to store and preserve the digital records than the manual and the physical ones.  Choosing The Best And The Most Professional Services For Healthcare Reports: • Rising Pharma Market for You Now In the market there are a host of companies that preserves the healthcare reports of the various patients. All of it is now being done in the digital format due to the adv...
Read more